Pretreatment attrition after rifampicin-resistant tuberculosis diagnosis with Xpert MTB/RIF or ultra in high TB burden countries

A systematic review and meta-analysis

Dados Bibliográficos

ID21879277
AutoresChristelle Geneviève Jouego (0000-0002-2591-8438, Molecular Diagnostics Research Group (MDRG), University of Yaoundé 1, Biotechnology Center, Nkolbisson, Cameroon), Tom Decroo (0000-0002-1205-1484, Unit of HIV and Tuberculosis, Institute of Tropical Medicine Department of Clinical Sciences, Antwerpen, Belgium), Palmer Masumbe Netongo (0000-0002-2341-6813, Molecular Diagnostics Research Group (MDRG), University of Yaoundé 1, Biotechnology Center, Nkolbisson, Cameroon), Tinne Gils (0000-0002-5518-9600, Unit of HIV and Tuberculosis, Institute of Tropical Medicine Department of Clinical Sciences, Antwerpen, Belgium)
Ano2025
Volume10
Fascículo1
Páginase015977
Data de publicação2025-01-01
Peer ReviewedSim
Open AccessSim
TipoARTICLE
PeriódicoBMJ Global Health (JOURNAL)
Identificadores do periódicoISSN: 2059-7908 • E-ISSN: 2059-7908
EditoraBMJ (PUBLISHER • GB)
DOI10.1136/bmjgh-2024-015977
IdiomaEN
Referências citadas34